MARCO and pancreatic neoplasm: Deficiency of MARCO was found to significantly inhibit tumor progression and metastasis in a mouse model of pancreatic cancer, and correlation of clinical data showed a strong trend toward poorer survival in patients with high CD163 and MARCO macrophage infiltration (32).